Advances in atopic dermatitis.


Journal

Clinical medicine (London, England)
ISSN: 1473-4893
Titre abrégé: Clin Med (Lond)
Pays: England
ID NLM: 101092853

Informations de publication

Date de publication:
05 2021
Historique:
entrez: 18 5 2021
pubmed: 19 5 2021
medline: 21 5 2021
Statut: ppublish

Résumé

Atopic dermatitis (AD) is a common inflammatory skin disease characterised by itch and is responsible for significant reduction in quality of life. While AD primarily arises in those under the age of 2 years, it is frequently persistent into adulthood. Recognition of AD is important for the general physician, especially to distinguish causes of acute flares that may present in any medical setting, such as eczema herpeticum and associated allergic reactions. While, to date, treatments have largely focused on broad spectrum immunomodulation with corticosteroids or systemic therapies (such as ciclosporin and methotrexate), increased knowledge in the pathophysiology of the disease has recently led to the expansion of treatment options available for those suffering with AD, and the new drugs on the horizon promise a previously unimagined potential for effective and safe treatment.

Identifiants

pubmed: 34001568
pii: 21/3/177
doi: 10.7861/clinmed.2021-0280
pmc: PMC8140689
doi:

Substances chimiques

Adrenal Cortex Hormones 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

177-181

Commentaires et corrections

Type : CommentIn

Informations de copyright

© Royal College of Physicians 2021. All rights reserved.

Références

J Allergy Clin Immunol Pract. 2020 Jan;8(1):91-101
pubmed: 31474543
J Invest Dermatol. 2014 Jun;134(6):1527-1534
pubmed: 24166134
J Invest Dermatol. 2012 Mar;132(3 Pt 2):751-62
pubmed: 22158554
Clin Med (Lond). 2016 Feb;16(1):66-9
pubmed: 26833520
JAMA Dermatol. 2020 Aug 1;156(8):863-873
pubmed: 32492087
J Invest Dermatol. 2013 Oct;133(10):2372-2380
pubmed: 23528819
Ann Allergy Asthma Immunol. 2021 Jan;126(1):13-20
pubmed: 32497711
Am J Clin Dermatol. 2020 Dec;21(6):783-798
pubmed: 32776305
Ann Allergy Asthma Immunol. 2018 Sep;121(3):340-347
pubmed: 30025911
Br J Dermatol. 1994 Sep;131(3):406-16
pubmed: 7918017
Br J Dermatol. 2019 Oct;181(4):796-804
pubmed: 30737999
N Engl J Med. 2016 Dec 15;375(24):2335-2348
pubmed: 27690741
Infect Dis Clin North Am. 2020 Jun;34(2):211-234
pubmed: 32334983
JAMA Dermatol. 2020 Dec 1;156(12):1333-1343
pubmed: 33001140
J Am Acad Dermatol. 2021 Feb;84(2):300-311
pubmed: 33038471
J Allergy Clin Immunol. 2020 Mar;145(3):877-884
pubmed: 31786154
J Allergy Clin Immunol. 2013 Feb;131(2):428-33
pubmed: 23245818

Auteurs

Alice Plant (A)

University Hospital Southampton NHS Foundation Trust, Southampton, UK alice.plant@uhs.nhs.uk.

Michael R Ardern-Jones (MR)

University of Southampton Faculty of Medicine, Southampton, UK and Southampton General Hospital, Southampton, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH